Free Trial

Aligos Therapeutics (ALGS) Short Interest Ratio & Short Volume

Aligos Therapeutics logo
$18.20 -0.30 (-1.62%)
(As of 11/20/2024 ET)

Aligos Therapeutics Short Interest Data

Aligos Therapeutics (ALGS) has a short interest of 121,300 shares, representing 4.78% of the float (the number of shares available for trading by the public). This marks a 46.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 80,047 shares to cover all short positions.

Current Short Interest
121,300 shares
Previous Short Interest
82,800 shares
Change Vs. Previous Month
+46.50%
Dollar Volume Sold Short
$1.19 million
Short Interest Ratio
0.8 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
3,588,000 shares
Float Size
2,540,000 shares
Short Percent of Float
4.78%
Today's Trading Volume
473,319 shares
Average Trading Volume
80,047 shares
Today's Volume Vs. Average
591%
Short Selling Aligos Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Aligos Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALGS Short Interest Over Time

ALGS Days to Cover Over Time

ALGS Percentage of Float Shorted Over Time

Aligos Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024121,300 shares $1.19 million +46.5%4.8%0.8 $9.78
10/15/202482,800 shares $601,956.00 -31.0%3.7%1.3 $7.27
9/30/2024120,000 shares $1.04 million +245.8%5.3%2 $8.66
9/15/202434,700 shares $513,560.00 +132.9%1.5%0.6 $14.80
8/31/202414,900 shares $188,932.00 +18.3%0.7%0.4 $12.68
8/15/202412,600 shares $151,231.50 -95.5%0.6%0.6 $12.00
7/31/2024281,100 shares $146,172.00 +13.1%N/A0.7 $0.52
7/15/2024248,500 shares $126,710.15 -88.5%N/A0.6 $0.51
6/30/20242,160,000 shares $756,000.00 +16.8%N/A5.6 $0.35
6/15/20241,850,000 shares $925,000.00 -0.5%N/A6.2 $0.50
5/31/20241,860,000 shares $1.10 million +69.1%N/A6 $0.59
5/15/20241,100,000 shares $747,010.00 +31.2%N/A2.9 $0.68
4/30/2024838,500 shares $641,452.50 +27.6%N/A2.2 $0.77
4/15/2024657,200 shares $587,996.84 -24.4%N/A1.7 $0.89
3/31/2024868,800 shares $851,424.00 +137.6%N/A2.3 $0.98
3/15/2024365,600 shares $336,900.40 -1.0%N/A0.9 $0.92
2/29/2024369,100 shares $365,409.00 +16.4%N/A0.8 $0.99
2/15/2024317,100 shares $203,578.20 -64.6%N/A0.8 $0.64
1/31/2024894,500 shares $617,205.00 +6.4%N/A3 $0.69
1/15/2024840,400 shares $619,458.84 -1.7%N/A2.8 $0.74
12/31/2023855,200 shares $567,852.80 -1.1%N/A3.1 $0.66
12/15/2023864,400 shares $505,760.44 +14.2%N/A4.1 $0.59
11/30/2023756,900 shares $529,830.00 +4.4%2.4%4.6 $0.70
11/15/2023724,800 shares $456,624.00 -1.3%2.3%9.2 $0.63
10/31/2023734,600 shares $440,760.00 -3.4%4.1%10.1 $0.60
10/15/2023760,700 shares $562,918.00 +1.0%2.8%10.8 $0.74
9/30/2023753,300 shares $562,715.10 -1.6%2.8%10.7 $0.75
9/15/2023765,200 shares $612,160.00 +0.6%2.9%10.1 $0.80
8/31/2023761,000 shares $655,221.00 +2.6%2.9%7.7 $0.86
8/15/2023742,100 shares $693,863.50 -4.5%2.8%6.9 $0.94
7/31/2023776,800 shares $691,352.00 -3.3%2.8%3.5 $0.89
7/15/2023803,500 shares $827,605.00 -1.7%2.9%3.8 $1.03
6/30/2023817,600 shares $793,889.60 +4.1%3.0%3.9 $0.97
6/15/2023785,700 shares $864,270.00 -14.3%2.9%3.7 $1.10
5/31/2023917,000 shares $1.04 million +25.0%3.4%4.5 $1.13
5/15/2023733,500 shares $953,550.00 -5.3%2.7%3.6 $1.30
4/30/2023774,500 shares $898,420.00 -0.3%2.8%7.7 $1.16
4/15/2023776,800 shares $722,346.32 -6.8%2.8%5.8 $0.93
3/31/2023833,000 shares $728,042.00 -4.4%3.0%2.8 $0.87
3/15/2023871,200 shares $1.17 million +2.0%3.3%2.2 $1.34
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

2/28/2023853,900 shares $1.25 million +16.2%2.9%2.1 $1.46
2/15/2023735,100 shares $1.19 million +0.7%2.5%1.8 $1.62
1/31/2023730,300 shares $1.42 million +128.4%2.7%1.8 $1.94
1/15/2023319,800 shares $524,472.00 -17.6%1.2%0.9 $1.64
12/30/2022387,900 shares $369,629.91 -3.5%1.4%1.8 $0.95
12/15/2022402,100 shares $381,995.00 +3.2%1.5%4.6 $0.95
11/30/2022389,500 shares $389,500.00 -7.1%1.4%5.2 $1.00
11/15/2022419,300 shares $427,686.00 +17.6%1.5%5.7 $1.02
10/31/2022356,700 shares $374,535.00 +1.1%1.6%4.8 $1.05
10/15/2022353,000 shares $388,300.00 +4.6%1.6%4.5 $1.10
9/30/2022337,600 shares $371,360.00 -13.5%1.5%3.4 $1.10
9/15/2022390,300 shares $519,099.00 +11.7%1.7%2.6 $1.33
8/31/2022349,300 shares $436,625.00 -20.2%1.6%2.1 $1.25
8/15/2022437,800 shares $682,968.00 -13.3%2.0%2.1 $1.56
7/31/2022505,000 shares $626,200.00 -17.9%2.3%1.7 $1.24
7/15/2022614,800 shares $965,236.00 -72.4%2.8%1.9 $1.57
6/30/20222,230,000 shares $2.70 million -22.0%10.0%6.8 $1.21
6/15/20222,860,000 shares $3.75 million -3.4%12.9%7.8 $1.31
5/31/20222,960,000 shares $3.82 million +2.1%12.6%8.3 $1.29
5/15/20222,900,000 shares $3.39 million +11.5%12.3%7.8 $1.17
4/30/20222,600,000 shares $3.07 million +7.9%10.3%7.4 $1.18
4/15/20222,410,000 shares $3.74 million +4.8%9.5%5.7 $1.55
3/31/20222,300,000 shares $4.95 million +3.1%9.1%4 $2.15
3/15/20222,230,000 shares $5.26 million +5.7%8.8%4.1 $2.36
2/28/20222,110,000 shares $5.11 million +0.5%8.4%4.1 $2.42
2/15/20222,100,000 shares $5.54 million +3.5%8.3%4.3 $2.64
1/31/20222,030,000 shares $6.48 million +6.3%8.0%4.3 $3.19
1/15/20221,910,000 shares $6.49 million -15.5%7.3%5.4 $3.40
12/31/20212,260,000 shares $26.83 million +3.7%8.7%8.3 $11.87
12/15/20212,180,000 shares $27.14 million +2.8%8.4%11.9 $12.45
11/30/20212,120,000 shares $32.48 million +10.4%8.1%10.5 $15.32
11/15/20211,920,000 shares $32.35 million -3.5%7.4%9.6 $16.85
10/29/20211,990,000 shares $31.70 million +2.6%7.8%10.1 $15.93
10/15/20211,940,000 shares $30.87 million +2.1%7.6%9.3 $15.91
9/30/20211,900,000 shares $29.47 million +9.2%7.4%7.8 $15.51
9/15/20211,740,000 shares $28.28 million -3.3%6.8%5.6 $16.25
8/31/20211,800,000 shares $30.69 million -3.2%7.0%6.8 $17.05
8/13/20211,860,000 shares $29.24 million +1.1%7.3%7.2 $15.72
7/30/20211,840,000 shares $26.81 million +4.6%7.7%7.3 $14.57
7/15/20211,760,000 shares $27.24 million +2.9%7.3%8.2 $15.48
6/30/20211,710,000 shares $34.86 million +9.6%7.1%9 $20.39
6/15/20211,560,000 shares $44.43 million -0.6%7.2%18.2 $28.48
5/28/20211,570,000 shares $43.77 million -2.5%7.4%22.2 $27.88
5/14/20211,610,000 shares $36.40 million -1.2%8.2%25.2 $22.61
4/30/20211,630,000 shares $44.17 million +1.9%8.4%26.3 $27.10
4/15/20211,600,000 shares $34.53 million +3.2%7.8%24.1 $21.58
3/31/20211,550,000 shares $32.35 million No Change7.5%23 $20.87
3/15/20211,550,000 shares $40.52 million +3.3%7.5%13.2 $26.14
2/26/20211,500,000 shares $42.09 million +10.3%7.3%9.8 $28.06
2/12/20211,360,000 shares $31.73 million +3.8%6.6%8.3 $23.33
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

1/29/20211,310,000 shares $34.56 million +4.0%6.1%7.5 $26.38
1/15/20211,260,000 shares $43.02 million No Change5.8%6.8 $34.14

ALGS Short Interest - Frequently Asked Questions

What is Aligos Therapeutics' current short interest?

Short interest is the volume of Aligos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 121,300 shares of ALGS short. 4.78% of Aligos Therapeutics' shares are currently sold short. Learn More on Aligos Therapeutics' current short interest.

What is a good short interest ratio for Aligos Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALGS shares currently have a short interest ratio of 1.0. Learn More on Aligos Therapeutics's short interest ratio.

What is a good short interest percentage for Aligos Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.78% of Aligos Therapeutics' floating shares are currently sold short.

Is Aligos Therapeutics' short interest increasing or decreasing?

Aligos Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 121,300 shares, an increase of 46.5% from the previous total of 82,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Aligos Therapeutics' float size?

Aligos Therapeutics currently has issued a total of 3,588,000 shares. Some of Aligos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aligos Therapeutics currently has a public float of 2,540,000 shares.

How does Aligos Therapeutics' short interest compare to its competitors?

4.78% of Aligos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aligos Therapeutics: Assembly Biosciences, Inc. (0.18%), Lifecore Biomedical, Inc. (7.91%), Atyr PHARMA INC (2.03%), Fate Therapeutics, Inc. (13.96%), Benitec Biopharma Inc. (0.25%), Pyxis Oncology, Inc. (13.30%), Aurora Cannabis Inc. (5.16%), Trevi Therapeutics, Inc. (2.24%), Biomea Fusion, Inc. (30.19%), TScan Therapeutics, Inc. (5.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Aligos Therapeutics stock?

Short selling ALGS is an investing strategy that aims to generate trading profit from Aligos Therapeutics as its price is falling. ALGS shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aligos Therapeutics?

A short squeeze for Aligos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALGS, which in turn drives the price of the stock up even further.

How often is Aligos Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALGS, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ALGS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners